Current strategies in engaging oncolytic viruses with antitumor immunity

Oncolytic virotherapy has produced promising yet limited results in preclinical and clinical studies. Besides direct oncolytic activity, a significant therapeutic mechanism of oncolytic virotherapy is the induction of tumor-specific immunity. Consequently, the efficacy of oncolytic viruses can be im...

Descripción completa

Detalles Bibliográficos
Autores principales: Boagni, Drew Ashton, Ravirala, Divya, Zhang, Shaun Xiaoliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411207/
https://www.ncbi.nlm.nih.gov/pubmed/34514092
http://dx.doi.org/10.1016/j.omto.2021.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411207/
https://www.ncbi.nlm.nih.gov/pubmed/34514092
http://dx.doi.org/10.1016/j.omto.2021.05.002

Ejemplares similares